Last updated 2026-07-26
- Raised $35M Series A, Nov 2023
- Raised grant, Dec 2023
- Raised grant, Dec 2022
Total raised
$35.0M
Last: Grant 2024-01
Stage
Series A
Founded
2013
Headcount
26
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
New Phase is an Israeli deep-tech company developing a unique treatment system for metastatic solid tumors. The technology utilizes Sarah Nanoparticles (SaNP) containing superparamagnetic iron oxide, which are injected intravenously and accumulate in tumor cells. An external Electromagnetic Induction System (EIS) then generates an alternating magnetic field to heat the nanoparticles to 50°C, causing hyperthermic damage to cancer cells while sparing healthy tissue. The company's mission is to transform metastatic cancer into a manageable disease, prolonging life and improving patients' quality of life.
Funding history · 3 rounds · $35.0M total
2023-12
Grant
Undisclosed
2023-11
A Round
$35.0M
2022-12
Grant
Undisclosed
Headcount over time
From 11 (2021-03) to 25 (2025-10) · +14 (+127%) · 31 points · source: Finder history + radar grounding
Q&A
- What is New Phase's primary focus?
- New Phase is an Israeli deep-tech company developing a unique treatment system for metastatic solid tumors using nanoparticle-based tumor-targeting molecules.
- When was New Phase founded?
- New Phase was founded in August 2013.
- What is the core technology developed by New Phase?
- New Phase's technology utilizes Sarah Nanoparticles (SaNP) containing superparamagnetic iron oxide, which are injected intravenously and accumulate in tumor cells. An external Electromagnetic Induction System (EIS) then heats the nanoparticles to 50°C, causing hyperthermic damage to cancer cells.
- How much funding has New Phase raised in total?
- New Phase has raised a total of $57,500,000 USD.
- When did New Phase receive its most recent grant?
- New Phase received a grant in January 2024.
- What was the amount of New Phase's A Round in December 2023?
- In December 2023, New Phase closed an A Round for $35,000,000 USD.
- What is the current employee count for New Phase?
- New Phase has 26 employees, which falls into the 11-50 employee bucket.
- Which organization provided a grant to New Phase in January 2023?
- The BIRD Foundation provided a grant to New Phase in January 2023.
- Has New Phase received FDA approval for clinical trials in the U.S.?
- According to news from June 9, 2024, New Phase's cancer treatment received FDA approval for clinical trials in the U.S.
- Who are the co-founders of New Phase?
- The co-founders of New Phase are Ofer Shalev and Dr. Rafi Hof.
Team · 2
Ofer Shalev
Founder · Co-founder & CEO
Dr. Rafi Hof
Founder · Co-founder & Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingBiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticalsMedical Devices Industry
Business model
B2B
Highlights
1 PatentsVerified
Tags
therapeuticsnanotechnologycellsmedical-devicesbiotechnologycell-therapycancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | newphase.co.il/ |
|---|---|
| linkedin.com/company/70902387 |
Identifiers & details
| Legal name | New Phase Ltd. |
|---|---|
| Founded | 2013-8 |
| Employees (exact) | 26 |
Radar intelligence
Patents
| EPO | 34 |
|---|
Web history (Wayback)
| Domain | newphase.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514957620 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2013-08-08 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — people (1) |
| Registered address | אודם 5 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-19 | עדכון דירקטורים-הוספת דירקטור |